TRIB News & Events

Trinity Biotech files to sell 35.28M American Depositary Shares for holders

Trinity Biotech has entered into a $25M Standby Equity Purchase Agreement with an affiliate of financing partner Yorkville Advisors Global. The agreement provides Trinity Biotech with an additional funding tool designed to augment the Company's commercialisation initiatives and to support its high-potential R&D programs.

Trinity Biotech received notice from Nasdaq that the company no longer meets the requirement in Nasdaq Listing Rule 5450 that listed securities maintain a minimum market value of publicly held shares of $15M, based on Nasdaq's review of the company's MVPHS for the last 30 consecutive business days.

Trinity Biotech received notice from Nasdaq that the company is not in compliance with Nasdaq Listing Rule 5450, requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the company's American Depositary Shares for the last 30 consecutive business days.